70518-1487-0 : NDC 2026 Code

70518-1487-0 : Dolutegravir Sodium ( Tivicay )

Additionally :

You can get information about “70518-1487-0” NDC code in 70518-1487-0 in HTML format

HTML | 70518-1487-0 in TXT (Plain Text) format

TXT | 70518-1487-0 in PDF (Portable Document Format)

PDF | 70518-1487-0 in XML format

XML formats.

NDC Code : 70518-1487-0 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "70518-1487-0",
    "PackageDescription": "30 TABLET, FILM COATED in 1 BLISTER PACK (70518-1487-0) ",
    "NDC11Code": "70518-1487-00",
    "ProductNDC": "70518-1487",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Tivicay",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Dolutegravir Sodium",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20181006",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA204790",
    "LabelerName": "REMEDYREPACK INC.",
    "SubstanceName": "DOLUTEGRAVIR SODIUM",
    "StrengthNumber": "50",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2022-06-09",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20231231",
    "StartMarketingDatePackage": "20181006",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}